CMS Open Payments · Program Year 2024
Lifeward, Inc.
Lifeward, Inc. reported $3,415.92 across General Payments, Research, and Ownership to 58 physicians and teaching hospitals across 58 transactions.
- $3.4K Below-median payer
- All-tracks total
- 58 Below-median volume
- Transactions
- 58 Below-median reach
- Recipients
- #1755
- of 1,925 companies
Lifeward, Inc. reported $3,415.92 across all CMS Open Payments tracks (General + Research + Ownership) to 58 physicians and teaching hospitals in Program Year 2024 - ranking #1755 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,415.92, averaging $58.90 per recipient.
Lifeward, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lifeward-inc Lifeward, Inc.
$3.4K · #1755/1,925 · 0.0% industry · PY2024
- TOT $3.4K
- RANK #1755
- SHARE 0.0%
- TXN 58
- RCP 58
- CAT 1
- GEN $3.4K
- TOP1 13.0%
- PY 2024
Volume peers
Nearest volume peer: Xiros Inc ($3.4K)
Lifeward, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Lifeward, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Lifeward, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $3.4K across 58 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 1 types of general payments, Lifeward, Inc.'s largest category was "Food and Beverage" at $3.4K - 100.0% of General Payments.
How Lifeward, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $3.4K | 58 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,135.79 (33.2%) of $3,415.92 in this company's General Payments records across 42 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lifeward, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Keith Tansey
$443.30 across 5 reported transactions
- 2
Isaac Hernandez Jimenez
$180.98 across 2 reported transactions
- 3
Elizabeth Twist
$180.97 across 2 reported transactions
- 4
Binnan Ong
$165.27 across 1 reported transactions
- 5
Cassandra Buchanan Renfro
$165.27 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lifeward, Inc. ranks #1755 of 1,925 by total payments (bottom 9% by spend) but is notably more concentrated than that alone would suggest -- #1,282 of 1,838 by HHI (bottom 30% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Life Spine, Inc. : $327.4K total payments, HHI 523
- Sarepta Therapeutics, Inc. : $2.8M total payments, HHI 522
- Exeltis, USA Inc. : $704.0K total payments, HHI 519
- EnableCV Inc. : $11.6K total payments, HHI 517
- Ostial Corporation : $8.4K total payments, HHI 515
- 3Shape Inc : $19.3K total payments, HHI 512
- Lifeward, Inc. (this company) : $3.4K total payments, HHI 510
- Heron Therapeutics, Inc. : $907.0K total payments, HHI 510
- ITF Therapeutics LLC : $67.9K total payments, HHI 510
- Active Medical, LLC : $34.6K total payments, HHI 509
- Insight Medical Systems, Inc. : $174.6K total payments, HHI 507
- CoapTech, Inc. : $4.0K total payments, HHI 506
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lifeward, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lifeward, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lifeward, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Meitheal Pharmaceuticals, Inc.
Avion Pharmaceuticals
BonaliveInc
Argentum Medical
Northern X-Ray Company
Put this to use
Lifeward, Inc. ranks #1755 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Lifeward, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.